Nuveen
OSTX icon

Nuveen’s OS Therapies Inc OSTX Stock Holding History

Nuveen’s Portfolio OSTX Stock Details OSTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.89K Buy
+1,794
New +$2.94K ﹤0.01% 4784

Other funds holding OSTX

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Howard Financial Services
Howard Financial Services Dallas, Texas $954M AUM 13.71% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return
Sanders Morris Harris
Sanders Morris Harris Houston, Texas $755M AUM 11.28% 1-Year Est. Return
StoneX Group
StoneX Group New York $2.75B AUM 24.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Armstrong Advisory Group
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Nuveen's OSTX Position: Q3 2026 in Review

Nuveen opened a new position in OS Therapies Inc (OSTX) in Q3 2026: 1,794 shares worth $2.89K. The stake represents ﹤0.01% of the portfolio and ranks #4784 among its holdings.

9 funds tracked by Wall St. Rank hold OSTX as of Q3 2026.

  • Nuveen held 1,794 shares of OS Therapies Inc worth $2.89K as of Q3 2026.
  • OS Therapies Inc was a new Nuveen position in Q3 2026.
  • OS Therapies Inc made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4784 holding.
  • 9 funds tracked by Wall St. Rank held OS Therapies Inc as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.